States with strict abortion regulations are pursuing legal challenges seeking to restrict the interstate distribution of abortion medication, including claims under public nuisance law. Louisiana, Alabama, and Arkansas are challenging shield laws in New York, California, and Massachusetts. They argue that these protections interfere with their ability to enforce state bans against providers who prescribe pills to residents within their borders.
Legal strategy and the public nuisance claim
The plaintiff states contend that the distribution of medication across state lines undermines laws enacted within their jurisdictions. This legal strategy relies on public nuisance doctrine, which traditionally addresses conduct that interferes with rights shared by the public. Public nuisance claims have historically appeared in disputes involving matters such as environmental contamination, and states are now seeking to apply the doctrine to abortion medication.
Public nuisance litigation can provide governments with a route to seek injunctive or other remedies against allegedly harmful conduct. Yet each state must prove the specific elements of the claim and show that the relief it seeks is permissible under law. No court has determined that the conduct challenged in these proceedings constitutes a public nuisance, and the claims remain contested.
Read Also: Florida Forces Meta to Restrict Facebook, Instagram for Teens
The Dobbs decision and conflicting regimes
The dispute stems from the Supreme Court’s 2022 ruling in Dobbs v. Jackson Women’s Health Organization, which reversed Roe v. Wade and concluded that the Constitution provides no abortion right. In the aftermath, a number of states have enacted sweeping bans, whereas other jurisdictions have passed statutes shielding clinicians who deliver reproductive services to individuals residing in more restrictive states.
Abortions that rely on medication typically use mifepristone together with misoprostol. The FDA first authorized mifepristone in 2000, and it continues to be permitted at the federal level. Because of that nationwide clearance, state attempts to limit its availability encounter a complex regulatory layer. The lawsuits raise multiple legal issues, such as whether the doctrine of public nuisance can extend to cross-state drug distribution and how far state abortion statutes may reach.
Attorneys General from the plaintiff states, Liz Murrill of Louisiana, Steve Marshall of Alabama, and Tim Griffin of Arkansas, assert that the distribution of medication undermines their state laws. Meanwhile, the defending states view their shield laws as measures protecting healthcare providers who operate lawfully under their own legislation. The dispute therefore places competing state regulatory regimes directly against each other.
